Analysis of Technical Intelligence of Tumor Cell Therapy Based on Patent Map

Abstract

Objective To analyze the technical information in the field of tumor cell therapy in China, and to provide reference for identifying technical trends and predicting technical opportunities. Methods Based on the patent data in the field of tumor cell therapy in China, the patent map method was used to construct a scientific technical information analysis model. Then, the technical status of new drug research and development in this field was explored to identify technical opportunities. Results and Conclusion Studies have found that China’s tumor immunotherapy is in the growth stage. The technical innovation regions are mainly distributed in the east and innovative entities are enterprises. Technology hotspots are concentrated in areas such as A61P35, C12N5, and the patented technical efficacy is high. Besides, the technical research and development opportunities identified are closely related to the background in this field. To better promote the development of the industry, enterprises and research institutions should strengthen cooperation in technological innovation Meanwhile, they should pay attention to technical efficacy analysis to identify more technical opportunities, thereby effectively guiding innovation strategic decisions.

Keywords

patent map / tumor immunotherapy / technical intelligence analysis / technical opportunity

References

[1] Huang Di, Gong Chang, Song Erwei. Adoptive immune cell therapy for malignant tumors moves from “individualization” to “precision”[J]. Chinese Bulletin of Life Sciences, 2019, 31 (7): 651-659.

[2] Yang Chen, Wang Chuhan, Tao Wanying, et al. Patent-based technology opportunity identification: A case study based on deep learning[J]. Science and Technology Management Research, 2021, 41 (12): 172-176.

[3] Li Hong, Yang Xiangfei. The review of the research on patent mapping application in R&D opportunity discovery[J]. Science & Technology Progress and Policy, 2015, 32 (16): 155-160.

[4] Nie Zewen, Zhang Wenfeng, Li Qian, et al. Analysis of technical opportunities in the field of traditional Chinese medicine antidepressants from the perspective of patent[J]. Chinese Journal of New Drugs, 2021, 30 (22): 2042-2048.

[5] Zhang Xinchen. Research on the technology status and industrial development strategy of piezoelectric ceramic actuators based on patent analysis[J]. China Invention & Patent, 2021, 18 (9): 36-43.

[6] Yang Wu, Sun Shiqiang, Chen Pei. Analysis of influencing factors of patent value from the perspective of technology locking[J]. Studies in Science of Science, 2022, 40 (6): 1024-1033.

[7] Teng Fei, Sun Yuling, Chen Fang, et al. Technology opportunity discovery of proton exchange membrane fuel cells based on generative topographic mapping[J]. Technological Forecasting & Social Change, 2021, 169: 120859.

[8] Ma Tianlei. The clinical efficacy evaluation of DC-CIK-CTL cell immunotherapy in combination with chemotherapy intervention for advanced cancer patients[D]. Hebei Medical University, 2020.

[9] Wickström S, Lövgren T. Expansion of tumor-infiltrating lymphocytes from melanoma tumors[J]. Methods in Molecular Biology (Clifton, N.J.), 2019, 1913: 105-118.

[10] Kiaie SH, Sanaei MJ, Heshmati M, et al. Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development[J]. Acta Pharmaceutica Sinica B, 2021, 11 (5): 1083-1097.

[11] Xu Longchang, Wei Wei. Research challenges and review considerations for TCR T cell therapy[J]. Chinese Journal of Biologicals, 2020, 33 (3): 355-360.

[12] Zhang Jing, Wang Jianxun. Optimization strategies for the treatment of multiple myeloma with CAR-T cells[J]. Journal of Modern Oncology, 2022, 30 (8): 1520-1523.

[13] Cheng Binbin. Discovery of novel inhibitors targeting the PD-1/PD-L1 interaction as potential anticancer agents[D]. Southern Medical University, 2021.